Telix Pharmaceuticals: Building A Radiopharma Powerhouse
Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
In a report released today, Laura Sutcliffe from UBS maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a ...
Vietnam Investment Review on MSN4d
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed ...
Yahoo Finance9d
Telix Pharmaceuticals Limited (TLPPF)
MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S ...
Wilsons Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
In a report released on March 21, Shane Storey from Wilsons maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), ...
Anne Whitaker Appointed as Non-Executive Director
Ms. Whitaker is an accomplished C-suite leader, most recently as Chair and CEO of Aerami Therapeutics Holdings Inc. During her executive career she has held senior leadership roles at GlaxoSmithKline ...
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
(ARTMS), a global leader in radioisotope production technologies, is pleased to announce that the drug master file (DMF) 1 for gallium-68 production using its QUANTM Irradiation System® (QIS®) ...
Business Insider4d
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase ...